Come join Bionow and Lancaster University for a co-hosted dynamic business pitching event, designed to bring together the exciting Life science and Biomedical sectors.
These Business Pitching events provide a unique opportunity for organisation in and supporting the sector to elevate their presence, discover cutting-edge innovations, and forge valuable connections.
Biotech & Beers Returns to Newcastle! All welcome.
Biotech & Beers returns to Alderley Park at The Churchill Tree the evening before Bruntwood SciTech's Suppliers Fair Event.
📖 Read November's eNews here
✅ Tony Jones, CEO, One Nucleus - Partnering, Policies and Parties
✅ Genesis Conference App Now Open! Start Your Networking Here...
✅ New Government Delivers Optimism and Concern for the Region’s Life Sciences by Tony Jones
✅ CRISPR – A Twist in the Tale in the Ongoing Patent Battle in Europe, by Appleyard Lees IP LLP
This virtual course will focus on the analysis of data from genomic studies of cancer. It will also highlight the application of transcriptomic analysis and single-cell technologies in cancer. Talks and interactive sessions will give an insight into the bioinformatic concepts required to analyse such data, whilst practical sessions will enable the participants to apply statistical methods to the analysis of cancer genomics data under the guidance of the trainers.
This course which takes place at the European Bioinformatics Institute will provide an introduction to metabolomics through lectures and hands-on sessions, using publicly available data, software, and tools. Participants will become familiar with standardised workflows as well as with the current state of experimental design, data acquisition (LC-MS, MS imaging), processing, and modelling. In addition, they will learn about community standards and sharing in metabolomics, particularly through the use of EMBL-EBI’s MetaboLights repository and Galaxy infrastructure.
Proteomics is a cutting-edge research area that examines proteins. These diverse and dynamic molecules are responsible for the execution of most biological processes and provide valuable indicators of human health and disease.
Read More Here
Company Description:
PharmaVentures is a premier transaction advisory firm based in the London Area, United Kingdom, specializing in partnering, M&A deals, and strategic alliances for over 30 years. With expertise in licensing, mergers, acquisitions, and divestments, PharmaVentures provides comprehensive support for companies worldwide. The company is known for its deep insight into deal structures and successful partnering strategies.
At One Nucleus, international connectivity is more than just a concept; it is at the core of what our members do and hence why we seek to complement that connectivity in how we support members. Whilst much of what One Nucleus delivers is done within the greater Cambridge-London region, our connectivity extends far beyond the UK.
By Tony Jones, CEO, One Nucleus
Recent weeks have been filled with varying degrees of anticipation and apprehension with regards to what UK government would start crystallising from grand election campaign gestures to actual measures and policies. After what felt like a long run of warnings of doom to the finally delivered ‘Invest 2025: the UK’s modern industrial strategy’ and ‘Autumn Budget 2024’.